Skip to main content
. 2021 Sep 20;44(12):1918–1929. doi: 10.1007/s00270-021-02975-2

Table 1.

Baseline patient demographics, medical history, and additional procedures

Patient demographics PTS subgroup N = 93 NIVL subgroup N = 77 All treated N = 170
Age (years), X ± SD 49.8 ± 15.0 55.0 ± 15.4 52.1 ± 15.3
Male/Female, % / % 45.2/54.8 27.3/72.7 37.1/62.9
BMI, kg/m2 ± SD 28.6 ± 6.4 29.1 ± 7.7 28.8 ± 7.0
Race, % (n)
Caucasian 89.2 (83) 94.8 (73) 91.8 (156)
African American 7.7 (7) 2.6 (2) 5.3 (9)
Asian 3.2 (3) 1.3 (1) 2.4 (4)
Medical history, % (n)
Varicose Veins 76.3 (71) 80.5 (2) 78.2 (133)
May–Thurner Syndrome 37.6 (35) 87.0 (67) 60.0 (102)
Deep Vein Thrombosis 98.9 (92) 0 (0) 54.1 (92)
Cigarette Smoking 30.1 (28) 39.0 (30) 34.1 (58)
Hypertension 29.0 (27) 36.4 (28) 32.4 (55)
Dyslipidemia 21.5 (20) 35.1 (27) 27.6 (47)
Respiratory Disorder 14.0 (13) 9.1 (7) 11.8 (20)
Diabetes 5.4 (5) 16.9 (13) 10.6 (18)
Peripheral Arterial Disease 6.5 (6) 15.6 (12) 10.6 (18)
Gastrointestinal Disease 11.8 (11) 9.1 (7) 10.6 (18)
Coronary Artery Disease 6.5 (6) 11.7 (9) 8.8 (15)
Coronary Intervention 6.5 (6) 10.4 (8) 8.2 (14)
Venous Valve Disease 7.5 (7) 6.5 (5) 7.1 (12)
Inferior Vena Cava Filter 10.8 (10) 0 (0) 5.9 (10)
Additional procedures1, % (n)
Previous Procedure2 20.4 (19) 13.0 (10) 17.1 (29)
30-Day Planned Procedure3 9.7 (9) 2.6 (2) 6.5 (11)

1Some patients had multiple procedures

2Procedure within 1 year of the study; most peripheral vascular interventions were for vena cava filter placement (33%), thrombectomy (16%), or venous procedures (e.g., venoplasty, ablation, or lysis)

3Planned peripheral endovascular or surgical intervention 30 days before or after the study procedure